GlassScriptPhysician profile
George Elias
NPI 1538173786
$893.12
in general payments reported to CMS, 2019-2025
10 companies · $328 in 2025
The $328 reported for 2025 was more than what 77% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $52.60 · 2022: $92.97 · 2023: $216 · 2024: $204 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $319.93 | 2022-2025 | |
| Lilly USA, LLC | $266.04 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $102.65 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $47.27 | 2023-2024 | Evenity, Prolia |
| Abbott Laboratories | $37.84 | 2023-2025 | Freestyle Libre, Freestyle Libre 3 |
| Pfizer INC. | $33.89 | 2020 | |
| Dexcom, INC. | $22.87 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $22.11 | 2025 | Gardasil 9, Capvaxive |
| Exact Sciences Corporation | $21.81 | 2025 | The Cologuard Plus Collection Kit |
| Radius Health, INC. | $18.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Elias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.